Toll-like receptors, chemokine receptors and death receptor ligands responses in SARS coronavirus infected human monocyte derived dendritic cells

The SARS outbreak in 2003 provides a unique opportunity for the study of human response to a novel virus. The etiological agent was identified to be a coronavirus (CoV) originating from an animal reservoir [1, 2]. Clinically, patients presented with an atypical pneumonia followed by diffuse alveolar damage, with mortality up to 52% in patients over 65 years old. Interestingly, the disease presentations of SARS were less severe in children than adults, and none of the infected children (< 12 years old) died of SARS [3, 4]. Evidences in the literature, including ours, support the role of immune evasion in the severity and immunopathology of SARS (Reviewed by [5–7]), and we further suggested that the developmental status of the host immune system may be responsible for the age-dependence of disease severity in SARS.

In our previous report [8], we have demonstrated that dendritic cells (DCs), the key antigen presenting cells with crucial role in anti-viral immune responses, might also be involved in the immune escape mechanisms for SARS-CoV. There was entry and incomplete replication of SARS-CoV in DCs but there was no production of infectious virus released into the culture medium [8]. SARS-CoV infection did not lead to DCs apoptosis or DC maturation.

Interestingly, the SARS-CoV infected DCs showed low expression of antiviral cytokines (IFN-α, IFN-β, IFN-γ and IL-12p40), moderate upregulation of proinflammatory cytokines (TNF-α and IL-6) but significant upregulation of inflammatory chemokines (macrophage inflammatory protein (MIP)-1α/CCL3, regulated upon activation, normal T cell expressed and secreted (RANTES)/CCL-5, interferon-inducible protein of 10 kD (IP-10)/CXCL10 and monocyte chemotactic protein (MCP)-1/CCL2. We postulated that this lack of antiviral cytokine response against a background of intense chemokine upregulation could represent a mechanism of immune evasion by SARS-CoV.

In the current study, we focused on the receptor responses in SARS-CoV infected DCs and compared adult and cord blood (CB) DCs to establish possible explanation for the age dependent severity of SARS. DCs express a wide range of receptors for the recognition of conserved pathogen patterns as well as the induction of subsequent immune responses. Some Toll like receptors (TLRs) are expressed on the cell surface (TLR-1, TLR-2, TLR-4, TLR-5, TLR-6, TLR-10) while some are located within intracellular compartments (TLR-3, TLR-7, TLR-8, TLR-9) [9]. They are differentially expressed in different DC subsets and are modulated in response to a variety of stimuli [10, 11]. Viral proteins may bind to TLR-2 or TLR-4, single stranded RNA binds to TLR-7 and TLR-8, and double stranded RNA binds TLR-3 while viral DNA binds to TLR-9. The binding of ligands to TLRs may trigger downstream signaling pathways that are involved in both the cytokine release during the primary induction of inflammation and secondary activation of anti-inflammatory mechanisms [12]. Cross talks between TLRs are common and the formation of TLR heterodimers allows a higher level of complexity in ligand-receptor binding and subsequent signaling.

The migration of DCs from peripheral tissues to lymph nodes is essential for antigen presentation and triggering of adaptive immune responses. The trafficking of DCs is regulated by chemokines in their microenvironment and their expression of chemokine receptors (CCRs). Differential expressions of CCRs are observed during DC maturation [13, 14] and some viruses, such as herpes simplex virus (HSV), can block CCR expressions on DCs to alter their migratory properties [15]. There are redundancies in the chemokines and CCRs interactions as many different ligands bind the same receptor and many receptors bind the same ligand. For example, RANTES binds to CCR-1, CCR-3 and CCR-5, while MIP-1α also binds to CCR-1 and CCR-5 [16]. We determined if the expression of these receptors on DCs are altered by SARS-CoV and contribute to autocrine regulation of DC migration.

Death receptors (DRs) and their ligands also play important roles in innate and adaptive immune responses by regulating cell death and survival [17]. Well-characterized death receptor ligands (DRLs) include tumor necrosis factor (TNF)-α, FasL and TNF-related apoptosis-inducing ligand (TRAIL/Apo2L). Recently, several viruses, including measles virus [18], human immunodeficiency virus (HIV) [19], cytomegalovirus (CMV) [20], and herpes simplex virus (HSV) [21], were shown to induce TRAIL expression on DCs. These "killer DCs" may be involved in the killing of virus-infected cells or bystander lymphocytes and natural killer cells. In view of the lymphopenia observed in SARS patient, we determine if DRLs expression on DCs is modulated by SARS-CoV.

This study provides evidence that SARS-CoV does not alter the TLRs, but modulates CCRs and DLRs expression in DCs; and further suggests possible mechanisms of immune escape and amplification of immunopathology in SARS.

Dendritic cells are professional antigen presenting cells that play an important role as sentinels at the infection site by interacting directly with pathogens. Some pathogens hijack different parts of the immune pathways involving DCs to enhance their survival. In the present study, we demonstrate that SARS-CoV does not have significant effect on the expression of TLRs on adult or CB DCs (Figs. 1 &2). However, there was significant upregulation of CCR-1 and CCR5 in SARS-CoV infected adult DCs and CCR-3 in SARS-CoV infected CB DCs which may be related to the autocrine regulation of DC migration (Fig. 3). Moreover, we demonstrate a significant upregulation of TRAIL on both adult and CB DCs (Fig. 4). We hypothesize that the upregulation of chemokine receptors may facilitate the autocrine mobilisation of DCs away from the infection sites and the upregulation of death receptor liganads may result in apoptosis of other immune cells, leading to immunosuppression and lymphopenia.

TLRs are expressed on many cell types and their expression on different DC subsets have been characterised. Visintin et al. [22] measured TLR expression on immature human DCs by monoclonal antibodies binding, but the expression was very low, corresponding to a few hundred molecules or less in immature DCs. Subsequent studies of TLRs expressions were based on comparing RNA expression quantitatively and some reports for immature DCs have been controversial. Our detection of TLR-1 to TLR-9 expressions in mock infected adult DCs were consistent with that reported by Jarrossay et al. [10] and the low level of TLR-10 was similar to that reported by Kadowaki et al. [11].

Viruses may subvert the TLR response to evade the host defense by: (a) producting specific viral particles that block TLR function, (b) blocking TLR recognition and (c) stimulating viral replication through TLRs [23]. Viral infections, by RSV or influenza A, have been shown to upregulate TLR-3 and TLR-4 expression in host airway epithelial cells, leading to increased signalling activity and proinflammatory cytokine production [23]. More recently, TLR-4 was shown to be upregulated in mice with acid-induced or inactivated avian influenza-induced lung injuries; and TLR-4 deficient mice showed less severe acute lung injuries to these challenges [24]. We, therefore, determined if SARS-CoV may modulate the TLRs expression on DCs. In this study, there was no induction nor suppression of TLRs in SARS-CoV infected DCs (Figs. 1 &2). The variations between samples were high, but the expression levels of some extracellular TLRs (TLR-1, TLR-2, TLR-4, TLR-5) and some intracellular TLRs (TLR-7, TLR-8) in CB DCs were higher than that in adult DCs (Table 1). Further investigation is needed to determine if the expression is responsible for the slightly higher Type I inferferon expression reported in CB DCs [8] and to identify any correlation with less severe SARS in children. Interestingly, impaired immune responses to TLR-3 and TLR-4 ligands have been reported in CB DCs [25].

The majority of TLR research is focussed on the downstream signalling pathways triggered by the binding of specific ligands to TLRs. Activation of TLRs induce signalling cascades which activate transcription factors and gene expression for anti-inflammatory responses [9]. The identification of such ligands may have therapeutic applications for the treatment of SARS. In a recent study on the control of coronavirus infection by plasmocytoid DCs (pDCs), it was demonstrated that mouse hepatitis virus (MHV) induces Type I IFN response and the recognition of MHV is mediated by TLR7 [26]. The authors demonstrated that SARS-CoV also induced a strong Type I interferon response in human pDCs and proposed that TLR7 may play a similar role in SARS-CoV infection. Another group developed a recombinant mouse-adapted SARS-CoV (rMA15) that was lethal in BALB/c mice and demonstrated that MyD88 played an important role in SARS-CoV pathogenesis [27]. Both groups suggested the involvement of TLR7/MyD88/IFNα dependent signaling and further exploration is needed to determine if TLR7 agonist may elicit potent antiviral effects against SARS-CoV infection.

To date, approximately 50 chemokines and 20 CCRs have been identified in humans [16] and they play important roles in inflammation and infectious diseases [28]. In our previous study, there was significant increase in the inflammatory chemokines (MIP 1α, RANTES, IP-10 and MCP-1) in SARS-infected DCs [8]. In addition, we have shown that SARS patients who have inherited the high-production gene allele of RANTES have more deaths [29]. In this study, we determined whether the expressions of representative CCRs (CCR1, CCR-3, CCR-5 and CCR-7) are also upregulated by SARS. Indeed, there was significant induction of CCR-1, CCR-3 and CCR-5 mRNA expression in SARS-CoV infected DCs (Fig. 3) suggesting the possibility of a autocrine loop in facilitating the trafficking of DCs. Therefore, further investigation into therapeutic strategies which aim at reducing chemokine and CCRs expresssion are warranted.

Among the CCRs studied, the upregulation of CCR-3 is the strongest (Fig. 3). It has been reported that the expression of CCR-3, unlike CCR-5 and CCR-7, are independent of the maturation status of DCs [13, 14]. Further investigation is needed to determine which mechanism is involved in CCR-3 upregulation. In addition to cell trafficking, CCR-3 has also been reported to function as a death receptor on B cells [30]. Whether CCR-3 expression is related to the characteristic antibody responses in SARS and the alternative function of CCRs on SARS-CoV infected DCs will need to be explored further.

CCR-7 has been identified as a key molecule for the establishment of central and peripheral tolerance. It is strongly upregulated in herpesvirus infected T cells [31], EBV infected B cells [32] and mature DCs [14]. In addition, microarray analysis of PBMC infected with SARS-CoV have shown an upregulation of CCR7 [33]. In this study, we only detected a slight but insignificant change in CCR-7 expression in adult SARS-CoV infected DCs (Fig. 3). This observation is consistent with previous findings that SARS-CoV did not stimulate DC maturation [8, 34]. However, this is in contrary to observations made by others [35, 36]. We speculate as these immature DCs migrate to the lymph nodes, they may act as regulatory DCs which are less effective for the activation of allogeneic CD4+ T cells than normal DCs [37] or they may drive the development of regulatory T cells [38]. These SARS-CoV-driven regulatory immature DCs may facilitate the immune evasion of SARS-CoV [39].

Interestingly, we detected significantly higher levels of chemokines and CCRs genes in CB DCs than in adults DCs. Based on the function of chemokines on cell trafficking, more severe infiltration of cells to the lungs would be expected in children. On the contrary, SARS was less severe in children than adults [3, 4]. The age-dependency of disease severity in SARS merits further studies to elucidate the underlying mechanisms. The development of animal models for SARS has been difficult because relevant signs of clinical illness and death cannot be reproducible in most animal models [40]. Recently, aged BALB/c mice have shown to develop more severe disease after SARS infection [41] and have lower vaccine efficacy than young mice [42]. The comparison of SARS-CoV infected senescent mice with adult mice can be extended to younger mice and knock out models for the study of age-dependency in the pathogenesis of SARS. A recent study has shown that mice deficient in either CCR1, CCR2 or CCR5 exhibited more prominent airway epithelial cell apoptosis and more severe lung pathology. This suggests that CCRs may be playing different roles at the site of infection and in the trafficking of immune cells [27].

Using real time quantitative assay, we have shown significant upregulation of TRAIL gene expression in avian influenza (H5N1) infected macrophages [43]. Similarly, SARS-CoV infected DC also showed a "killer DC' phenotype with high expression of TRAIL (Fig. 4). Comparing the two studies, the level of TRAIL expression in SARS-CoV infected adult DCs (~300 copies/10⁴ β actin genes) was lower than that in H5N1 infected adult macrophages (~1800 copies/10⁴ β actin genes). TRAIL expression in SARS-CoV infected CB DCs was the highest (~5000 copies/10⁴ β actin genes). Further investigation is needed to confirm the cytotoxic function of SARS-CoV infected DCs on immune cells. Based on the possible DC migration induced by chemokines and the role of TRAIL in inducing lymphocyte apoptosis, our findings may explain the white pulp atrophy in the spleen and lymphoid depletion in lymph nodes of SARS patients. The mechanism involved in children may be more complicated and it is important to determine if the CB DCs are functionally immature in spite of the high expression of chemokines, CCRs and TRAIL. More recently, TRAIL expression is also reported to be upregulated after the binding of HIV to TLR-7 [44] or activation of TLR-8 [45]. Hence the high TRAIL expression in SARS-infected CB DCs may also be related to their TLR-8 expression.

This study has characterized important receptor responses of DCs to SARS-CoV. The suggested mechanisms need to be substantiated by further research involving a larger sample size for different pathways as pathogens may have multiple ways to modify the physiology of DCs to their advantage.